Symptomatology and markers of anxiety disorders in Parkinson's disease: A cross-sectional study-Reference-Cited by-同舟云学术

Symptomatology and markers of anxiety disorders in Parkinson's disease: A cross-sectional study

Published:2011-02-10 Issue:3 Volume:26 Page:484-492
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov. Disord.

Author:

Leentjens Albert F. G.,Dujardin Kathy,Marsh Laura,Martinez-Martin Pablo,Richard Irene H.,Starkstein Sergio E.

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mds.23528/fullpdf

Reference29 articles.

1. Anxiety disorders in Parkinson's disease;Richard;Advances in Neurology,2005

2. Parkinson's disease and anxiety: comorbidity with depression;Menza;Biol Psychiatry,1993

3. Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease;Pontone;Mov Disord,2009

4. Anxiety rating scales in Parkinson's disease: a validation study of the Hamilton Anxiety Rating Scale, the Beck Anxiety Inventory and the Hospital Anxiety and Depression Scale;Leentjens;Mov Disord

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Longitudinal faster anxiety progression of GBA variant carriers in the early Parkinson’s disease cohort;Frontiers in Neuroscience;2024-01-24

2. A general clinical overview of the non-motor symptoms in Parkinson’s disease: Neuropsychiatric symptoms;International Review of Neurobiology;2024

3. Artificial intelligence empowering research on loneliness, depression and anxiety — Using Covid-19 as an opportunity;Journal of Safety Science and Resilience;2023-12

4. Functional Connectivity and Anxiety Improvement After Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease;Clinical Interventions in Aging;2023-08

5. Anxiety in synucleinopathies: neuronal circuitry, underlying pathomechanisms and current therapeutic strategies;npj Parkinson's Disease;2023-06-22